Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the ... Read More
-
The 2026-2031 World Outlook for Bisphosphonates
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Analgesic Osteoarthritis Treatments
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
Bone Densitometers
... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More
-
Osteoporosis Therapeutics
... CAGR of 2.9% over the analysis period 2024-2030. Bisphosphonates, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$8.1 Billion by the end of the analysis period. ... Read More
-
Hyaluronic Acid
... CAGR of 8.1% over the analysis period 2024-2030. Offline, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Animal Stem Cell Therapy Market By Product Type (Autologous Stem Cell Therapy and Allogeneic Stem Cell Therapy), By Type of Stem Cells (Mesenchymal Stem Cells, Hematopoietic Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells), By Application (Osteoarthritis, Skin regeneration, Neurodegenerative diseases, and Autoimmune diseases), Species (Dogs, Cats and Horses), and End-User (Veterinary Clinics, Research Laboratories and Universities and Academic Institutions ), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
... Cells), By Application (Osteoarthritis, Skin regeneration, Neurodegenerative diseases, and Autoimmune diseases), Species (Dogs, Cats and Horses), and End-User (Veterinary Clinics, Research Laboratories and Universities and Academic Institutions ), Global Market Size, Segmental analysis, Regional Overview, ... Read More
-
Veterinary Pain Management Market Report by Product (Drugs, Devices), Animal Type (Companion, Livestock), Application (Osteoarthritis and Joint Pain, Postoperative Pain, Cancer, and Others), End User (Hospitals and Clinics, and Others), and Region 2025-2033
... 2025-2033. There are several factors that are driving the market, which include the rising number of pet parents, various regulatory approvals, and increasing prevalence of chronic diseases such as arthritis, cancer, joint pain, and post-surgical ... Read More
-
2025 Global: Hip Osteoarthritis Pain Drug Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Postmenopausal Osteoporosis: Understanding Postmenopausal Osteoporosis: ... Read More
-
Postmenopausal Osteoporosis Market, by Drug Class (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors, Anabolic Class, Calcium Metabolism Modifiers, and Others (Calcitonin, Denosumab among Others)), by Route of Administration (Oral, Intravenous Route, and Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... of 50 is at risk of developing osteoporosis. It could be due to hormonal changes or a lack of calcium and vitamin D. Along with increased incidences of fractures in older, postmenopausal women, osteoporosis may ... Read More
-
Osteoporosis Drugs Global Market Opportunities And Strategies To 2034
... it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being affected by ... Read More
-
2025 Global Forecast for Hip Osteoarthritis Pain Drug Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Osteoporosis Drugs Markets in China
... which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply ... Read More
-
Osteoporosis Drugs Companies in China
... consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest ... Read More
-
Osteoporosis Drugs Industry Forecasts - China Focus
... China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for ... Read More
-
Global Bone and Joint Vitamins Market Growth 2025-2031
... 2025 to 2031. As we age, our bones lose strength, making them more susceptible to fractures, and joints become less flexible and can end up feeling stiff. For healthy bones and joints, staying active plays ... Read More
-
Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033
... increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market. Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular ... Read More
-
Global Osteoporosis Biosimilars Market Growth 2025-2031
... 2031. Osteoporosis biosimilars are a class of follow-up biologic products that are equivalent to approved osteoporosis biologic drugs in quality, safety and efficacy. They go through a rigorous regulatory process and demonstrate no significant differences ... Read More
-
Global Osteoporosis Testing Market - 2022-2029
... expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030). With mergers, acquisitions, and product launches, the global osteoporosis testing market is moderately competitive. Some of the key players in the market are ... Read More
-
Global Raloxifene Hydrochloride Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the ... Read More
-
Orthopedic Braces and Supports Market Size, Share, and Analysis, By Product (Knee, Shoulder, Ankle, Hand, and Elbow) By Type (Soft, Hinged, and Hard) By Application (ACL, Osteoarthritis, Compression, and Rehabilitation), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 PRODUCT OVERVIEW Orthopedic Braces and Supports Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast span from 2024 ... Read More
-
Osteoporosis_Global Clinical Trials Review, 2025
... trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), ... Read More
Research Assistance
